Read More 5 minute read Pharma Industry News Chimeric Therapeutics secures new funding boost as cancer cell therapy trials accelerate Discover how Chimeric Therapeutics' A$1M entitlement offer will drive innovation across CAR-T and NK cell therapy programs. Read the full story here. byPallavi MadhirajuApril 27, 2025